JOSHUA SWEET: Open Payments
NPI 1760944771 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,564 in 87 payments from 22 companies in 2025. Trend: 2023 $234 · 2024 $1,086 · 2025 $1,564
Food & beverage: $1,564
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $262 |
| ABBVIE INC. | 18 | $237 |
| Madrigal Pharmaceuticals | 8 | $194 |
| AstraZeneca Pharmaceuticals LP | 4 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $96 |
| Exact Sciences Corporation | 4 | $78 |
| Gilead Sciences, Inc. | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| ViiV Healthcare Company | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
Products named: REZDIFFRA, AIRSUPRA, VRAYLAR, Ozempic, Kerendia, Rybelsus, Cologuard Collection Kit, REXULTI.
Industry payments across NY — which companies pay providers there.
